The Performance of the Biotech Industry: Promise Versus Reality

Science Business: The Promise, the Reality, and the Future of Biotech

Pisano, Gary P.

  • チャプター
HBI

Throughout the history of biotech, expectations have been high. The promise of the industry was that the through different (and superior) technology, the process of drug R&D would be transformed, and this transformation would lead to an avalanche of new drugs, and, of course, fuel profitability. In addition, it has been widely expected and perceived that smaller biotech firms are more productive at R&D than established pharmaceutical giants. This chapter explores these assumptions, examining the performance of the biotech industry over thirty years and presenting data on financial returns, profitability, and R&D productivity. This chapter is excerpted from "Science Business: The Promise, the Reality, and the Future of Biotech."

出版日
2006/11
領域
経営・戦略
ボリューム
24ページ
コンテンツID
CCJB-HBS-6608BC
オリジナルID
6608BC
ケースの種類
Press Chapter
言語
英語
カラー
製本の場合、モノクロ印刷での納品となります。

関連ケース